Macy’s, Inc. announces the appointment of Cheryl Heinonen as EVP of corporate communications

CINCINNATI, 2016-Dec-22 — /EPR Retail News/ — Macy’s, Inc. (NYSE:M) announced today (Dec. 19, 2016) that Cheryl Heinonenhas been named executive vice president of corporate communications for Macy’s, Inc., effective Jan. 9, 2017.

Heinonen, a leading communications and public affairs professional, will be responsible for corporate communications (both internal and external), corporate giving, corporate social responsibility, diversity, and associate giving and volunteerism. She will report to Macy’s, Inc. President Jeff Gennette who becomes chief executive officer early next year. Heinonen will be based in New York City. In this new role, she will drive the strategic narrative of the company and integrate all internal communication into one cohesive strategy.

Heinonen is currently senior vice president, corporate relations and chief communications officer at Avon Products, Inc. where she is responsible for corporate communications, corporate social responsibility, and sustainability, responsibilities she has held since joining the company in 2012.

In November 2014, Heinonen also assumed the presidency of the Avon Foundation for Women, a public 501c3 charity dedicated to improving the lives of women and their families globally with a focus on breast cancer and domestic violence.

Heinonen will step down from her Avon Products, Inc. and Avon Foundation for Women roles effective Jan. 1, 2017. She will remain on the Avon Foundation board when she begins her career at Macy’s.

“Cheryl brings valuable expertise to the Macy’s executive team. She is a strategic communicator with an outstanding track record of connecting companies in a powerful way to employees, customers and a broad range of stakeholders,” Gennette said.

Prior to joining Avon, Heinonen was managing director at Burson-Marsteller, a leading global communications agency, where she advised some of the world’s top consumer brands on communications and reputation management. Her areas of focus included corporate social responsibility, organizational communications, and consumer branding and international public affairs. Before assuming her role at Burson-Marsteller, Heinonen worked at Visa, most recently as senior vice president of global corporate relations.

Heinonen earned a bachelor’s degree in political science from Bryn Mawr College in Pennsylvania.

Macy’s, Inc., with corporate offices in Cincinnati and New York, is one of the nation’s premier retailers, with fiscal 2015 sales of $27.079 billion. The company operates about 880 stores in 45 states, the District of Columbia, Guam and Puerto Rico under the names of Macy’s, Bloomingdale’s, Bloomingdale’s Outlet, Macy’s Backstage and Bluemercury, as well as the macys.com, bloomingdales.com and bluemercury.com websites. Bloomingdale’s in Dubai is operated by Al Tayer Group LLC under a license agreement.

All statements in this press release that are not statements of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based upon the current beliefs and expectations of Macy’s management and are subject to significant risks and uncertainties. Actual results could differ materially from those expressed in or implied by the forward-looking statements contained in this release because of a variety of factors, including conditions to, or changes in the timing of, proposed real estate and other transactions, prevailing interest rates and non-recurring charges, store closings, competitive pressures from specialty stores, general merchandise stores, off-price and discount stores, manufacturers’ outlets, the Internet, mail-order catalogs and television shopping and general consumer spending levels, including the impact of the availability and level of consumer debt, the effect of weather and other factors identified in documents filed by the company with the Securities and Exchange Commission.

(NOTE: Additional information on Macy’s, Inc., including past news releases, is available at www.macysinc.com/pressroom.)

Contact:
Media:
Holly Thomas
646-429-5250

Investors:
Matt Stautberg
513-579-7780

Source: Macy’s, Inc.

New breast cancer study funded by Avon Foundation for Women shows higher mortality rate among Black women in the U.S.

NEW YORK, NY, 2016-Oct-05 — /EPR Retail News/ — Today (October 3, 2016 ), the Avon Foundation for Women released a new study on the Black:White disparities in breast cancer mortality in the 50 largest cities in the United States between 2005 and 2014, which was conducted by Sinai Urban Health Institute in collaboration with the Breast Cancer Research Foundation and funded by the Avon Foundation for Women.

This new study is the most comprehensive longitudinal analysis of the direction and magnitude of disparities in breast cancer mortality among Black and White women by city. The study revealed that Black women continue to die from breast cancer at a higher rate than their White counterparts in the United States, and that the Black:White disparity increased across the country as a whole.

“Avon Foundation recognized early on that there was a significant need to understand these racial disparities in order to focus efforts and resources where they are most needed,” said Cheryl Heinonen, President of the Avon Foundation for Women. “As the company for women, Avon puts women at the center of everything we do. This is part of our DNA, our history and our legacy to empower women and improve the quality of life of women. And this requires collaboration at all levels.”

Between 2010 and 2014, the breast cancer mortality rate for Black women was 30.7 deaths per 100,000 women and for White women it was 21.4 deaths per 100,000 women. Nationally, Black women were 43 percent more likely to die from breast cancer than their White counterparts.

For each of the cities examined, the study provided the breast cancer mortality rates for White and Black women, along with a ranking of the cities based on their racial disparities. Atlanta experienced the largest increase in the Black:White disparity over the study period. However, there was a statistically significant decrease in the disparity in Memphis, Philadelphia, and Boston.

“Examining mortality and disparities data at the city level is imperative in the ongoing challenge to eliminate health disparities and achieve health equity,” said Bijou Hunt, an epidemiologist and co-author of the study at the Sinai Urban Health Institute, who has been spearheading research on disparities in breast cancer mortality rates among African Americans and Hispanics. “These types of data inform local health officials who, given their unique understanding of their respective cities’ available and potential resources, are in ideal positions to develop and implement strategies for improvement.”

More research is needed to understand why this disparity is growing, though causes could include a lack of early detection, late stage diagnosis, and delayed treatment. Overall the study concluded that there is a critical need to increase access to breast cancer screening and treatment services for African American women.

“It was important to note that some individual cities have shown a decreasing disparity and there is much we can learn from those that are doing well,” said Dr. Marc S. Hurlbert of the Breast Cancer Research Foundation, and former Executive Director of the Avon Foundation for Women. “However, the Black:White disparity in breast cancer mortality still exists and needs to be addressed as a public health problem.”

Breast cancer continues to be the second leading cause of cancer death among women in the United States, with an estimated 40,450 deaths expected to occur in 20161. Local-level data like these are not readily available, but can be extremely useful for public health officials seeking to understand trends and improve health outcomes in their local jurisdictions. This research is a promising step toward better understanding of the disparities and ways to overcome barriers to care and improve access to breast cancer prevention screenings, diagnostics and treatment.

The Avon Breast Cancer Crusade which launched in 1992, has placed Avon and the Avon Foundation for Women at the forefront of the fight against breast cancer. Today, Avon is the leading corporate supporter of the cause globally, donating more than $800 million to breast cancer programs for research and advancing access to care, regardless of a person’s ability to pay.

Sources:

[1] American Cancer Society. Cancer Facts & Figures 2016. In. Atlanta: American Cancer Society; 2016.

About the Avon Breast Cancer Crusade
Since 1992, the Avon Breast Cancer Crusade has been working to improve breast cancer outcomes and reduce disparities in survival rates. The Crusade’s strategic grant making reflects: a holistic and place-based approach in high-need areas throughout the United States; a commitment to enabling access to medical advances and support services for breast cancer patients, particularly those from vulnerable populations; and a commitment to investing in research on the prevention, diagnostics, and treatment of breast cancer. In the U.S., Avon Breast Cancer Crusade manages the Avon Foundation for Women’s breast cancer programs. The Avon Foundation for Women partners with affiliate Avon Foundations and Avon markets around the world for additional programming. In total, Avon and the Foundation have contributed more than $800 million to breast cancer programs around the world through 2015. To learn more, visit: www.avonfoundation.org.

About Avon and the Avon Foundation for Women 
Avon is a global corporate leader in philanthropy focused on causes that matter most to women. Through 2015, Avon and the Avon Foundation for Women have contributed over $1 billion in over 50 countries. Avon’s funding is focused on breast cancer research and advancing access to quality care through the Avon Breast Cancer Crusade, and efforts to reduce domestic and gender violence through its Speak Out Against Domestic Violence program. The company’s global markets sell special products to raise awareness and funds for breast cancer and domestic violence, conduct hundreds of events for these causes, and educate women around the world through its global network of nearly six million Avon Representatives.

About Sinai Urban Health Institute
Sinai Urban Health Institute (SUHI) is a diverse group of epidemiologists, research assistants, and community health educators who are involved in social epidemiology, program implementation and evaluation, teaching, and consulting. Founded in 2000 as part of Sinai Health System, SUHI’s mission is grounded in the belief that in order to serve our constituents well, we need to understand not just the patients who enter our doors but the community at-large. A major component of SUHI’s work involves examining the impact of social issues, such as poverty, on health. In addition to research, SUHI does teaching through formal courses, grand round lectures, and other seminars and presentations.

About Breast Cancer Research Foundation
The Breast Cancer Research Foundation (BCRF) is dedicated to being the end of breast cancer by advancing the world’s most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment and survivorship. This year, BCRF has awarded $57 million in grants to support the work of more than 250 scientists at leading medical and academic institutions across 14 countries, making BCRF the largest private funder of breast cancer research worldwide. By committing 91 cents of every dollar directly to its mission, BCRF is one of the nation’s most fiscally responsible nonprofits. BCRF is the only breast cancer organization in the US to hold both an “A+” from CharityWatch as well as the top four-star rating from Charity Navigator. Visit www.bcrfcure.org to learn more.

Media Contacts:

Liz Micci
The Glover Park Group
+1 (646) 495-2700
emicci@gpg.com

Kristina Jorge
Avon Corporate Communications
+1 (212) 282-5852
Kristina.Jorge@avonusa.com

Source: Avon

Avon Foundation funded study explores breast cancer prevalence and mortality rates among U.S. Hispanics and Hispanic subgroups

MIAMI, FLA., 2016-Sep-12 — /EPR Retail News/ — Today (SEPTEMBER 8, 2016), at the Avon Breast Cancer Crusade’s biennial Breast Cancer Forum, healthcare providers, breast cancer survivors, and leading care advocates from across the nation gathered for the release of the new Avon Foundation funded study: Breast Cancer Among Hispanic Subgroups in the U.S., which was conducted by Sinai Urban Health Institute.

The study is the first and most comprehensive study of its kind to explore breast cancer prevalence and mortality rates among U.S. Hispanics and Hispanic subgroups. The study revealed that breast cancer mortality rates differ for Cuban, Mexican, Puerto Rican, and Central and South American women with breast cancer in the U.S.

Puerto Rican women (19.04 per 100,000 women) and Mexican women (18.78) have the highest breast cancer mortality rates of all Hispanic women with breast cancer in the U.S. Central and South American women in the U.S. were found to be significantly less likely to die from breast cancer than other Hispanic subgroups observed (10.15 per 100,000 women).

“Understanding where the greatest needs are in improving the lives of women with breast cancer is a fundamental first step to bringing about change in how this disease is addressed, particularly in the Hispanic community,” said Cheryl Heinonen, President of the Avon Foundation for Women. “As the company for women, Avon is committed to taking actions that matter most to women and that is why the Avon Foundation is passionate about funding studies like this. We want to identify where the disparities lie so we can effectively shape and support programs that will have the greatest impact.”

At the briefing, remarks from a diverse panel of guests were featured, including: Cheryl Heinonen, Bijou R. Hunt, the author of the Avon Foundation funded study from the Sinai Urban Health Institute at Sinai Health System, Jenny Saldaña, who serves as an Avon Breast Cancer Crusade Patient Navigator at New-York Presbyterian Hospital/Columbia University Medical Center, and Paola Giorello, a breast cancer survivor who benefited from the Avon Foundation-funded Patient Navigator program at Nueva Vida Inc. in Alexandria, Va.

“What this research has uncovered has the potential to greatly improve individualization of care for Hispanic women with breast cancer,” said Bijou R. Hunt of the Sinai Urban Health Institute. “When healthcare providers begin to view the highly diverse population of Hispanic women as many unique groups – taking into account the ethnic identities, beliefs and cultures that could impact how they experience this disease – providers can better tailor their interventions and be even more culturally sensitive.”

Through the use of multiple national data sources and multiple years of data, the analysis in the Avon Foundation funded study: Breast Cancer Among Hispanic Subgroups in the U.S., presents data on

Hispanic subgroups that are not often accessible. More research is needed to understand why the disparities in mortality rates for various Hispanic subgroups exist. A wide number of factors including genetic traits, and differences in diet and lifestyle that may vary by culture could have a role to play in these variances; but more exploration is needed for these to be determined.

There are 56.6 million people of Hispanic origin in the U.S., making them the largest racial/ethnic minority in the country1. Breast cancer is the most commonly diagnosed cancer in Hispanic women, as well as the leading cause of cancer death for this group2. This research is a promising step toward better understanding and addressing this group’s diverse health needs.

The Avon Breast Cancer Crusade which launched in 1992, has placed Avon and the Avon Foundation for Women at the forefront of the fight against breast cancer. Today, Avon is the leading corporate supporter of the cause globally, donating more than $800 million to breast cancer programs for research and advancing access to care, regardless of a person’s ability to pay.

Sources:

[1] U.S. Census Bureau. Annual Estimates of the Resident Population by Sex, Age, Race, and Hispanic Origin for the United States and States: April 1, 2010 to July 1, 2015.

2 Society. AC. Center Facts & Figures for Hispanics/Latinos 2015-2017. In. Atlanta: 2015.

About the Avon Breast Cancer Crusade
Since 1992, the Avon Breast Cancer Crusade has been working to improve breast cancer outcomes and reduce disparities in survival rates. The Crusade’s strategic grant making reflects: a holistic and place-based approach in high-need areas throughout the United States; a commitment to enabling access to medical advances and support services for breast cancer patients, particularly those from vulnerable populations; and a commitment to investing in research on the prevention, diagnostics, and treatment of breast cancer. In the U.S., Avon Breast Cancer Crusade manages the Avon Foundation for Women’s breast cancer programs. The Avon Foundation for Women partners with affiliate Avon Foundations and Avon markets around the world for additional programming. In total, Avon and the Foundation have contributed more than $800 million to breast cancer programs around the world through 2015. To learn more, visit: www.avonfoundation.org.

About Avon and the Avon Foundation for Women 
Avon is a global corporate leader in philanthropy focused on causes that matter most to women. Through 2015, Avon and the Avon Foundation for Women have contributed over $1 billion in over 50 countries. Avon’s funding is focused on breast cancer research and advancing access to quality care through the Avon Breast Cancer Crusade, and efforts to reduce domestic and gender violence through its Speak Out Against Domestic Violence program. The company’s global markets sell special products to raise awareness and funds for breast cancer and domestic violence, conduct hundreds of events for these causes, and educate women around the world through its global network of nearly six million Avon Representatives.

CONTACT:

Kate Yee
251-406-0920
Kate.yee@finnpartners.com

Source: AVON